Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs
Keywords: SH2B1; RABEP1; Pharmacogenetics of psychotropic drugs; Metabolic syndrome in psychiatry; Dyslipidemia; Type 2 diabetes;